Cite
Moustafa A, Li W, Anderson EL, et al. Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease. Clin Transl Gastroenterol. 2018;9(1):e132doi: 10.1038/ctg.2017.58.
Moustafa, A., Li, W., Anderson, E. L., Wong, E. H. M., Dulai, P. S., Sandborn, W. J., Biggs, W., Yooseph, S., Jones, M. B., Venter, J. C., Nelson, K. E., Chang, J. T., Telenti, A., & Boland, B. S. (2018). Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease. Clinical and translational gastroenterology, 9(1), e132. https://doi.org/10.1038/ctg.2017.58
Moustafa, Ahmed, et al. "Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease." Clinical and translational gastroenterology vol. 9,1 (2018): e132. doi: https://doi.org/10.1038/ctg.2017.58
Moustafa A, Li W, Anderson EL, Wong EHM, Dulai PS, Sandborn WJ, Biggs W, Yooseph S, Jones MB, Venter JC, Nelson KE, Chang JT, Telenti A, Boland BS. Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease. Clin Transl Gastroenterol. 2018 Jan 18;9(1):e132. doi: 10.1038/ctg.2017.58. PMID: 29345635; PMCID: PMC5795019.
Copy
Download .nbib